Fisher Asset Management, LLC

Position in SRRK — Scholar Rock Holding Corp

CIK 850529 PLANO, TX

Position in SRRK

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$22,516,115

-$893,772 QoQ

Shares Held

458,017

-13.8% QoQ

Ownership

0.382%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 23.637113906252388.ToString("F0")% Shared 0.ToString("F0")% None 76.36288609374762.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fisher Asset Management, LLC holds $671,245,647 across 48 Biotechnology names. SRRK ranks #13 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	1,113,568	$69,820,713
2	CYTK	Cytokinetics Inc	768,264	$50,636,280
3	RCUS	Arcus Biosciences, Inc.	2,190,404	$47,312,726
4	DNLI	Denali Therapeutics Inc.	2,436,895	$46,788,384
5	VRDN	Viridian Therapeutics, Inc.\DE	1,768,295	$34,587,850
6	CLDX	Celldex Therapeutics, Inc.	1,013,648	$32,152,914
7	CGON	CG Oncology, Inc.	465,033	$31,473,433
8	IDYA	IDEAYA Biosciences, Inc.	882,699	$29,411,530

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,516,115	458,017	-13.8%	Shares	Defined	2026-05-05
2025-12-31	$23,409,887	531,439	-0.3%	Shares	Defined	2026-02-09
2025-09-30	$19,855,474	533,176	+29.3%	Shares	Defined	2025-11-12
2025-06-30	$14,607,597	412,411	-9.7%	Shares	Defined	2025-08-13
2025-03-31	$14,688,402	456,871	-17.6%	Shares	Defined	2025-05-14
2024-12-31	$23,975,733	554,737	-24.4%	Shares	Defined	2025-02-05
2024-09-30	$5,879,492	734,019	+593.6%	Shares	Defined	2024-11-12
2024-06-30	$881,588	105,833	0.0%	Shares	Defined	2024-08-14
2024-03-31	$1,879,594	105,833	-6.5%	Shares	Defined	2024-05-09
2023-12-31	$2,127,483	113,164	-19.8%	Shares	Defined	2024-03-05
2023-09-30	$1,001,490	141,055	0.0%	Shares	Sole	2023-11-13
2023-06-30	$1,063,554	141,055	—	Shares	Sole	2023-12-12
No filing history on record for this holder in this stock.